Shenzhen - Delayed Quote CNY

Dirui Industrial Co.,Ltd. (300396.SZ)

13.59
+0.28
+(2.10%)
At close: May 16 at 3:04:22 PM GMT+8
Loading Chart for 300396.SZ
  • Previous Close 13.31
  • Open 13.32
  • Bid 13.59 x --
  • Ask 13.60 x --
  • Day's Range 13.27 - 13.63
  • 52 Week Range 12.27 - 25.75
  • Volume 4,230,139
  • Avg. Volume 4,621,660
  • Market Cap (intraday) 3.706B
  • Beta (5Y Monthly) 0.26
  • PE Ratio (TTM) 104.54
  • EPS (TTM) 0.13
  • Earnings Date --
  • Forward Dividend & Yield 0.26 (1.91%)
  • Ex-Dividend Date May 20, 2025
  • 1y Target Est --

Dirui Industrial Co.,Ltd. engages in the research and development, production, and sale of medical inspection products in the People's Republic of China. The company provides medical instruments and supporting test strip reagents. It offers urine and biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory. Dirui Industrial Co.,Ltd. was founded in 1992 and is headquartered in Changchun, the People's Republic of China.

www.dirui.com.cn

1,821

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300396.SZ

View More

Performance Overview: 300396.SZ

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300396.SZ
16.83%
SSE Composite Index (000001.SS)
0.47%

1-Year Return

300396.SZ
45.83%
SSE Composite Index (000001.SS)
7.85%

3-Year Return

300396.SZ
7.69%
SSE Composite Index (000001.SS)
9.56%

5-Year Return

300396.SZ
32.99%
SSE Composite Index (000001.SS)
17.40%

Compare To: 300396.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300396.SZ

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    3.71B

  • Enterprise Value

    3.67B

  • Trailing P/E

    103.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.03

  • Price/Book (mrq)

    1.79

  • Enterprise Value/Revenue

    4.97

  • Enterprise Value/EBITDA

    129.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.85%

  • Return on Assets (ttm)

    -0.47%

  • Return on Equity (ttm)

    1.69%

  • Revenue (ttm)

    737.7M

  • Net Income Avi to Common (ttm)

    35.8M

  • Diluted EPS (ttm)

    0.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    393.26M

  • Total Debt/Equity (mrq)

    17.24%

  • Levered Free Cash Flow (ttm)

    -242.17M

Research Analysis: 300396.SZ

View More

Company Insights: 300396.SZ

Research Reports: 300396.SZ

View More

People Also Watch